Home › Compare › SAVNF vs JNJ

SAVNF vs JNJ: Dividend Comparison 2026

SAVNF yields 4024.14% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAVNF wins by $7604156211145.98M in total portfolio value
10 years
SAVNF
SAVNF
● Live price
4024.14%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7604156211146.01M
Annual income
$7,249,760,988,507,126,000.00
Full SAVNF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SAVNF vs JNJ

📍 SAVNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAVNFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAVNF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SAVNF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAVNF
Annual income on $10K today (after 15% tax)
$342,052.31/yr
After 10yr DRIP, annual income (after tax)
$6,162,296,840,231,056,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SAVNF beats the other by $6,162,296,840,231,052,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAVNF + JNJ for your $10,000?

SAVNF: 50%JNJ: 50%
100% JNJ50/50100% SAVNF
Portfolio after 10yr
$3802078105573.02M
Annual income
$3,624,880,494,253,565,400.00/yr
Blended yield
95.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SAVNF
No analyst data
Altman Z
13.1
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAVNF buys
0
JNJ buys
0
No recent congressional trades found for SAVNF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAVNFJNJ
Forward yield4024.14% ✓2.13%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28% ✓
Portfolio after 10y$7604156211146.01M ✓$30.3K
Annual income after 10y$7,249,760,988,507,126,000.00 ✓$4,689.40
Total dividends collected$7579987236278.96M ✓$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SAVNF vs JNJ ($10,000, DRIP)

YearSAVNF PortfolioSAVNF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$413,114$402,414.49$10,592$272.30+$402.5K → SAVNF
2$15,978,785$15,536,752.74$11,289$357.73+$15.97M → SAVNF
3$578,726,671$561,629,370.56$12,123$472.89+$578.71M → SAVNF
4$19,629,835,230$19,010,597,691.87$13,141$629.86+$19629.82M → SAVNF
5$623,640,032,747$602,636,109,051.73$14,408$846.81+$623640.02M → SAVNF
6$18,560,523,177,963$17,893,228,342,922.85$16,021$1,151.60+$18560523.16M → SAVNF
7$517,552,326,786,396$497,692,566,985,975.70$18,122$1,588.22+$517552326.77M → SAVNF
8$13,523,824,366,643,228$12,970,043,376,981,786.00$20,930$2,228.20+$13523824366.62M → SAVNF
9$331,210,488,447,554,600$316,739,996,375,246,340.00$24,792$3,191.91+$331210488447.53M → SAVNF
10$7,604,156,211,146,009,000$7,249,760,988,507,126,000.00$30,274$4,689.40+$7604156211145.98M → SAVNF

SAVNF vs JNJ: Complete Analysis 2026

SAVNF — Stock

Savannah Resources Plc explores for and develops lithium properties in Portugal. It holds interest in the Barroso lithium project located in northern Portugal. The company was formerly known as African Mining and Exploration plc and changed its name to Savannah Resources Plc in September 2013. Savannah Resources Plc was incorporated in 2010 and is based in London, the United Kingdom.

Full SAVNF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SAVNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAVNF vs SCHDSAVNF vs JEPISAVNF vs OSAVNF vs KOSAVNF vs MAINSAVNF vs ABBVSAVNF vs MRKSAVNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.